


OOO "NPF" Materia Medica Holding"
Pharmaceutical Manufacturing • Moscow, Moscow, Russian Federation • 101-200 Employees
Company overview
| Headquarters | Трифоновская улица 47, Москва, Москва 129272, RU |
| Phone number | +74956844333 |
| Website | |
| NAICS | 3254 |
| SIC | 283 |
| Founded | 1992 |
| Employees | 101-200 |
| Socials |
Key Contacts at OOO "NPF" Materia Medica Holding"
Vitaly Bystryukov
Head Of Sales And Marketing
Mikhail Putilovskiy
Clinical Research And Medical Information Director
Daniil Epstein
Deputy General Director
Evgeniya Kachaeva
Deputy Regulatory Affairs Director
Andrey Leechuck
Director Of International Business Department
Irina Kovalevskaya
Director Of Legal Department
Oksana Lutsenko
Personal Assistant To Chief Executive Officer
Olga Levitskaya
Project Management Director
Olga Baraliuc
Director
OOO "NPF" Materia Medica Holding" Email Formats
OOO "NPF" Materia Medica Holding" uses 1 email format. The most common is {last name} (e.g., doe@materiamedica.ru), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{last name} | doe@materiamedica.ru | 100% |
About OOO "NPF" Materia Medica Holding"
Research and Manufacturing company Materia Medica Holding is one of the major Russian pharmaceutical companies. It is the only Russian company manufacturing medicines of a new class based on ultra low doses of antibodies to endogenous regulators. Company's product portfolio includes OTC drugs of different pharmacological groups, such as immunomodulators, antiviral products, anti-inflammatory drugs, sedative drugs, nootropics, regulators of the urogenital system and reproductive system functions. The products are marketed in Russia and the CIS countries. For more than 10 years Materia Medica Holding has been carrying out fundamental research in the pharmacology of ultra low doses, and currently the company holds the leading position in this field. The staff of Materia Medica Holding exceeds 600 people. The company has its own production site in Chelyabinsk equipped with the up-to-date GMP-compliant facilities of European manufacturers. The efforts of the company’s staff for development and introduction into medical practice of new highly effective remedies based on ultra low doses of antibodies to endogenous regulators were recognized with Science & Technology Award 2005 and Science & Technology Award 2006 by Government of the Russian Federation (orders of the Government of the Russian Federation No. 96 dd. February 20th , 2006 AND No. 12 dd. February 22nd , 2007). We are trying to develop highly effective drugs able to solve the problems of treatment, prevention and rehabilitation in different medical areas. We believe that our products will help millions of people to be healthy.
OOO "NPF" Materia Medica Holding" revenue & valuation
| Annual revenue | $150,000,000 |
| Revenue per employee | $915,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $480,000,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 101-200
Seniority
Employees
Employees by Department
OOO "NPF" Materia Medica Holding" has 46 employees across 10 departments.
Departments
Number of employees
Funding Data
OOO "NPF" Materia Medica Holding" has never raised funding before.
OOO "NPF" Materia Medica Holding" Tech Stack
Discover the technologies and tools that power OOO "NPF" Materia Medica Holding"'s digital infrastructure, from frameworks to analytics platforms.
Security
Analytics
CMS
JavaScript libraries
Reverse proxies
Programming languages
JavaScript libraries
JavaScript libraries
Maps
Font scripts
Frequently asked questions
4.8
40,000 users



